Medication for Bloating and Dyspepsia
Start with a proton pump inhibitor (PPI) at the lowest effective dose as first-line therapy, as this has the strongest evidence for treating functional dyspepsia with high-quality data supporting efficacy and excellent tolerability. 1
Initial Diagnostic Step
Before initiating medication, test for Helicobacter pylori infection using stool antigen or breath testing. If positive, eradicate with appropriate antibiotic therapy, as this provides definitive treatment for H. pylori-positive dyspepsia with strong evidence. 1
First-Line Pharmacologic Treatment
After H. pylori testing (or if negative):
Proton Pump Inhibitors (Preferred)
- PPIs are the most strongly recommended first-line treatment with high-quality evidence 1
- Use the lowest dose that controls symptoms - there is no dose-response relationship
- Well-tolerated with minimal adverse effects
- Strong recommendation, high-quality evidence
Alternative First-Line Options
H2-receptor antagonists may be used if PPIs are not tolerated or preferred, though evidence is weaker (weak recommendation, low-quality evidence) 1
Prokinetics have variable efficacy depending on the specific agent:
- Tegaserod has moderate-quality evidence supporting use (strong recommendation) 1
- Acotiamide, itopride, and mosapride have low-quality evidence (weak recommendation) 1
- Important caveat: Most prokinetics are unavailable outside Asia and the USA 1
Second-Line Treatment for Refractory Symptoms
If first-line therapy fails after adequate trial:
Tricyclic Antidepressants (TCAs)
TCAs are the recommended second-line treatment functioning as gut-brain neuromodulators 1:
- Start amitriptyline 10 mg once daily at bedtime
- Titrate slowly to maximum 30-50 mg daily
- Strong recommendation, moderate-quality evidence
- Critical counseling point: Explain these work on gut-brain nerve sensitivity, NOT as antidepressants
- Warn about side effects (dry mouth, drowsiness, constipation)
- Can be initiated in primary or secondary care
Alternative Second-Line Options
Antipsychotics (sulpiride 100 mg four times daily or levosulpiride 25 mg three times daily) may be considered, but require careful explanation and counseling about side effects 1
Specific Consideration for Bloating
For patients where bloating is the predominant symptom:
Rifaximin (non-absorbable antibiotic) shows efficacy specifically for bloating in functional GI disorders 2
- Doses ≥1200 mg/day are more effective than lower doses
- Typically given 1-2 weeks
- 44.6% improvement vs 34.6% with placebo
- Consider if bloating persists despite acid suppression
Buspirone may specifically improve bloating severity based on recent meta-analysis 3, though overall dyspepsia symptom improvement was not significant
Non-Pharmacologic Foundation
Recommend regular aerobic exercise to all patients (strong recommendation, though evidence quality is very low) 1
Dietary modifications: Insufficient evidence to recommend specific diets like low-FODMAP routinely, though individual food trigger avoidance may help some patients 1
Critical Pitfalls to Avoid
- Do NOT use opioids - these cause harm in functional dyspepsia 1
- Avoid surgery for refractory symptoms 1
- Do not over-restrict diet without dietitian guidance - risk of malnutrition and disordered eating 1
- Ensure red flag symptoms are absent (age >55 at onset, weight loss >10%, GI bleeding, family history of gastric/esophageal cancer) before empiric treatment
Treatment Algorithm Summary
- Test and treat H. pylori if positive
- Start PPI (lowest effective dose) for 4-8 weeks
- If inadequate response: Add or switch to TCA (amitriptyline 10 mg, titrate to 30-50 mg)
- For persistent bloating: Consider rifaximin trial
- Refractory cases: Multidisciplinary team with gastroenterology, dietitian, psychology
This stepwise approach prioritizes treatments with the strongest evidence while recognizing that functional dyspepsia represents gut-brain axis dysfunction requiring both peripheral (acid suppression, prokinetics) and central (neuromodulators) therapeutic strategies.